Funds managed by Oberland Capital invested $100m in Northstar Medical, a global innovator in the production and distribution of radioisotopes. NorthStar received $75m at closing with the ability to draw an additional $25m prior to December 31, 2020 at the company’s option. "This financing agreement with Oberland Capital enables us to execute on our clearly defined strategy to build solid, sustainable momentum for NorthStar as a fully commercial enterprise,” said Stephen Merrick, President and Chief Executive Officer of NorthStar.